Ensuring patients with #cancer are well-informed about clinical trials is crucial! Proud to share our JAMA Oncology patient page, dedicated to ⬆️ inclusion & diversity in trial enrollment—#patienteducation is an important first step! 👥🔗 jamanetwork.com/journals/jamao… OncoAlert #lcsm

This paper & this table is GOLD 🥇 Words matter. I will be sharing this with my ICU trainees for years to come. Thank you Dr RanaAwdishMD & team 🙏🏾👏🏾 #meded

In 1️⃣ slide, Dr. Lana Elu, Université de Paris, describes the clinical & radiographic features of 🫁 T-DXd pneumonitis clinicians need to identity quickly and effectively diagnose & treat the condition. #ESMO24 OncoAlert

MASTERFUL discussion of #ILD w/ TDXd by Dr. Pat LoRusso 📍HER "low" expression in 🫁 - likely why worse w/ TDXd than other ADC targets ❗️Ethnicities such as Japanese 🇯🇵 at higher risk. 📛 Prior ILD, hepatic and renal impairment all risk factors #ESMO24 #ESMOAmbassadors

Day 4 #ESMO24 - what’s new in first line ovarian cancer treatment with Profs Nicolette Colombo and Isabelle Ray-Coquard

An excellent #crcsm #GeriOnc trial from our 🇯🇵 colleagues in Journal of Clinical Oncology 🚫 #PFS or #OS benefit to adding 💉 oxaliplatin to fluoropyrimidine for older adults 70+ mCRC 👴🧓. Only adding 💀☠️ #tox with #Ox #GIonc OncoAlert🚨 🔗: ascopubs.org/doi/10.1200/JC…

ADCs are among the most rapidly expanding treatment modalities in oncology, with 11 ADCs approved and >200 in active development. Here’s 10 facts to know to prepare for the rise of ADCs🧵

Happy #ACORD24! Many happy protocol-writing memories with Chris Brown Meera agar Martin Stockler Dr Antonia Pearson Michael Fisch MD MPH. Keep close watch over Jᴏᴇ Wᴇɪ representing Scientia Clinical Research (Sydney, Australia) as he is known to go rogue...

As #ACORD24 returns to PullmanMagentaShores, reflecting on where these protocols ended up. annabel smith Meera agar Ash Malalasekera #ACORD18

Curious about what a #GICancer #ClinicalTrial is and what one could involve? If you are interested in participating in a clinical trial, ask your doctor if there is a trial that's right for you. For more info, visit: gicancer.org.au/FAQ #CancerResearch

#AcademicChatter #AcademicX

🚨Highlights from #ESMO2024! Prof Dr Hans Prenen shares key findings on brachytherapy, immunotherapy in MSI-high rectal cancer, and anti-EGFR re-challenge in metastatic colon cancer. Watch now! 👀 medimix.be/onco/esmo-barc… #MediMix #Oncology #GICancer #CancerResearch #ClinicalTrials

Yeah that's probably me 😅